Inventor · disambiguated record
James Mclaughlin
Also filed as: MCLAUGHLIN JAMES · MCLAUGHLIN JAMES H · MCLAUGHLIN JAMES HUGH · SMITH JAMES A
12 granted patents·9 pending applications·252 citations·filing 1973–2020
92Inventor score
Files withGEMINI THERAPEUTICS INC5VOYAGER THERAPEUTICS INC4GEMINI THERAPEUTICS SUB INC3AIRWICK IND2CENTER FOR NEW PRODUCT DEV2
Top patents by PatentIndex Score
21 records- 0191US10577627B2Chimeric capsidsVOYAGER THERAPEUTICS INC·Filed 2015·Granted Mar 3, 2020·6 cites·28 claims
- 0283US3972804AControl of hydrogen/hydrocarbon mole ratio in hydrogen-consuming processUNIVERSAL OIL PROD CO·Filed 1974·Granted Aug 3, 1976·26 cites·12 claims
- 0382US4808322ASkin cleansing-cream conditioning barMCLAUGHLIN JAMES H·Filed 1988·Granted Feb 28, 1989·51 cites·21 claims
- 0480US4161449APowdered carpet compositionAIRWICK IND·Filed 1977·Granted Jul 17, 1979·29 cites·10 claims
- 0578US3974064AControl of hydrogen/hydrocarbon mole ratio and the control system thereforUNIVERSAL OIL PROD CO·Filed 1974·Granted Aug 10, 1976·20 cites·16 claims
- 0675US3963629AFabric softener composition for use in a clothes dryer and methodCENTER FOR NEW PRODUCT DEV·Filed 1973·Granted Jun 15, 1976·16 cites·5 claims
- 0774US4395347APowdered carpet cleaner containing ether alcohol solventsAIRWICK IND·Filed 1981·Granted Jul 26, 1983·32 cites·26 claims
- 0873US7749523B2Emollient skin conditioning cream and methodCRABTREE & EVELYN LTD·Filed 2001·Granted Jul 6, 2010·9 cites·19 claims
- 0973US4941990ASkin cleansing-cream conditioning barMCLAUGHLIN JAMES H·Filed 1989·Granted Jul 17, 1990·39 cites·27 claims
- 1067US12180500B2Chimeric capsidsVOYAGER THERAPEUTICS INC·Filed 2020·Granted Dec 31, 2024·0 cites·10 claims
- 1162US3976588ADetergents providing faster drying of cleansed substratesCENTER FOR NEW PRODUCT DEV·Filed 1975·Granted Aug 24, 1976·24 cites·8 claims
- 1251US2020291427A1Crispr-based therapeutics for targeting htra1 and methods of useGEMINI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1351US2020270614A1RNAi-BASED THERAPEUTICS FOR TARGETING HTRA1 AND METHODS OF USEGEMINI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1450US2020325481A1Antisense-based therapeutics for targeting htra1 and methods of useGEMINI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1546US2022396807A1Methods for treating patients having cfh mutations with cfh-encoding vectorsGEMINI THERAPEUTICS SUB INC·Filed 2020·Application pending·0 cites
- 1645US2022347265A1Methods for treating patients having cfi mutations with recombinant cfi proteinsGEMINI THERAPEUTICS SUB INC·Filed 2020·Application pending·0 cites
- 1745US2022395557A1Methods for treating patients having cfh mutations with recombinant cfh proteinsGEMINI THERAPEUTICS SUB INC·Filed 2020·Application pending·0 cites
- 1842US11697825B2Compositions and methods for the production of scAAVVOYAGER THERAPEUTICS INC·Filed 2015·Granted Jul 11, 2023·0 cites·42 claims
- 1940US2018245073A1Regulatable expression using adeno-associated virus (aav)VOYAGER THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2039US2021371480A1Compositions and methods for treating age-related macular degeneration and other diseasesGEMINI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2134US2021188927A1Compositions and methods for treating age-related macular degenerationGEMINI THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Mclaughlin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →